Skip to content
value.today

Akumin vs Bionano Genomics, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Akumin is the larger company by market value: $18 M against $17 M for Bionano Genomics, Inc., 1.1 times as much (market caps of Jul 30, 2023 for Akumin and Oct 30, 2026 for Bionano Genomics, Inc.). Akumin's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

05961192178923852020202120222023202420252026Akumin 7Bionano Genomics, Inc. 51

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B20182019202020212022202320242025Bionano Genomics, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAkumin
AKU.TO
Bionano Genomics, Inc.
BNGO · #24,825 in the world
Profile
Country🇨🇦 Canada🇺🇸 USA
SectorHealthcareHealthcare
IndustryDiagnostics and ResearchDiagnostics and Research
Founded—2003
Size
Market cap$18 M*$17 M
Revenue—$29 M
Net income—$-26 M
Employees—299
Valuation
Price to sales—0.5×
Price to book—0.4×
Profitability
Gross margin—46.3%
Operating margin—-116.9%
Net margin—-92.6%
Return on equity—-66.2%
Growth
Revenue growth—-7.4%
Revenue growth, 3 years a year—0.8%
Altman Z-score zone—distress
Data as ofMarket cap Jul 2023Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Akumin or Bionano Genomics, Inc.?

Akumin is the larger company by market value: $18 M against $17 M for Bionano Genomics, Inc., 1.1 times as much (market caps of Jul 30, 2023 for Akumin and Oct 30, 2026 for Bionano Genomics, Inc.). Akumin's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.